Literature DB >> 29308898

Synthesis of N-Substituted 3-Amino-4-halopyridines: A Sequential Boc-Removal/Reductive Amination Mediated by Brønsted and Lewis Acids.

Christopher A Wilhelmsen1, Alexandre D C Dixon1, John D Chisholm1, Daniel A Clark1.   

Abstract

N-Substituted 3-amino-4-halopyridines are valuable synthetic intermediates, as they readily provide access to n class="Chemical">imidazopyridines and similar heterocyclic systems. The direct synthesis of N-substituted 3-amino-4-halopyridines is problematic, as reductive aminations and base-promoted alkylations are difficult in these systems. A high yielding deprotection/alkylation protocol mediated by trifluoroacetic acid and trimethylsilyl trifluoromethanesulfonate is described, providing access to a wide scope of N-substituted 3-amino-4-halopyridines. This protocol furnishes many reaction products in high purity without chromatography. Similar reductive amination conditions were also established for deactivated anilines.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29308898      PMCID: PMC5835363          DOI: 10.1021/acs.joc.7b02966

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  14 in total

1.  Scope of the organocatalysed asymmetric reductive amination of ketones with trichlorosilane.

Authors:  François-Moana Gautier; Simon Jones; Xianfu Li; Stephen J Martin
Journal:  Org Biomol Chem       Date:  2011-09-29       Impact factor: 3.876

2.  Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures(1).

Authors:  Ahmed F. Abdel-Magid; Kenneth G. Carson; Bruce D. Harris; Cynthia A. Maryanoff; Rekha D. Shah
Journal:  J Org Chem       Date:  1996-05-31       Impact factor: 4.354

3.  New polyfunctional imidazo[4,5-C]pyridine motifs: synthesis, crystal studies, docking studies and antimicrobial evaluation.

Authors:  Gilish Jose; T H Suresha Kumara; Gopalpur Nagendrappa; H B V Sowmya; Jerry P Jasinski; Sean P Millikan; N Chandrika; Sunil S More; B G Harish
Journal:  Eur J Med Chem       Date:  2014-03-11       Impact factor: 6.514

4.  Copper- and palladium-catalyzed amidation reactions for the synthesis of substituted imidazo[4,5-c]pyridines.

Authors:  Robert J Wilson; Adam J Rosenberg; Lauren Kaminsky; Daniel A Clark
Journal:  J Org Chem       Date:  2014-02-17       Impact factor: 4.354

5.  Efficient access to azaindoles and indoles.

Authors:  Mark McLaughlin; Michael Palucki; Ian W Davies
Journal:  Org Lett       Date:  2006-07-20       Impact factor: 6.005

6.  4-phenoxypiperidines: potent, conformationally restricted, non-imidazole histamine H3 antagonists.

Authors:  Curt A Dvorak; Richard Apodaca; Ann J Barbier; Craig W Berridge; Sandy J Wilson; Jamin D Boggs; Wei Xiao; Timothy W Lovenberg; Nicholas I Carruthers
Journal:  J Med Chem       Date:  2005-03-24       Impact factor: 7.446

7.  Synthesis of imidazo[4,5-b]pyridines and imidazo[4,5-b]pyrazines by palladium catalyzed amidation of 2-chloro-3-amino-heterocycles.

Authors:  Adam J Rosenberg; Jinbo Zhao; Daniel A Clark
Journal:  Org Lett       Date:  2012-03-13       Impact factor: 6.005

8.  Design and synthesis of purine analogues as highly specific ligands for FcyB, a ubiquitous fungal nucleobase transporter.

Authors:  Nikolaos Lougiakis; Efthymios-Spyridon Gavriil; Markelos Kairis; Georgia Sioupouli; George Lambrinidis; Dimitra Benaki; Emilia Krypotou; Emmanuel Mikros; Panagiotis Marakos; Nicole Pouli; George Diallinas
Journal:  Bioorg Med Chem       Date:  2016-09-22       Impact factor: 3.641

9.  Nucleophilic addition to 3-substituted pyridinium salts: expedient syntheses of (-)-L-733,061 and (-)-CP-99,994.

Authors:  Alexandre Lemire; Michel Grenon; Mehrnaz Pourashraf; André B Charette
Journal:  Org Lett       Date:  2004-09-30       Impact factor: 6.005

10.  Synthesis of potential anticancer agents: imidazo[4,5-c]pyridines and imidazo[4,5-b]pyridines.

Authors:  C Temple; J D Rose; R N Comber; G A Rener
Journal:  J Med Chem       Date:  1987-10       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.